Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Vicarious Surgical Inc.RBOT · Entity 8714 | Director | May 10, 2023 | May 12, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Vicarious Surgical Inc.
Report date May 10, 2023 · Filed May 12, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectBy E15 Fund III, LP | 730,332 |
Reported balance
After 2023-05-10 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2023-05-10 · Purchase · Acquired 7,000 · Balance 730,332 F1: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction. F2: This figure is the weighted average purchase price of multiple transactions ranging from $1.9584 to $2.0450 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares purchased at each separate price upon request. F3: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Chelvey International Limited | 43,888 |
Reported balance
Holding disclosure · report date 2023-05-10 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 43,888 F4: Shares held directly by Chelvey International Limited. E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. The Reporting Person, as the managing partner of E15 Fund II, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund II, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund II, LP, except to the extent of any pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy E15 Fund Advisors (HK) Limited | 330,001 |
Reported balance
Holding disclosure · report date 2023-05-10 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 330,001 F5: Shares held directly by E15 Fund Advisors (HK) Limited. The Reporting Person, as the managing partner of E15 Fund Advisors (HK) Limited, may be deemed to share voting and dispositive power over the shares held by E15 Fund Advisors (HK) Limited. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund Advisors (HK) Limited, except to the extent of any pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | Direct | 1,153,019 |
Reported balance
Holding disclosure · report date 2023-05-10 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 1,153,019 |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction.
F2: This figure is the weighted average purchase price of multiple transactions ranging from $1.9584 to $2.0450 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares purchased at each separate price upon request.
F3: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein.
F4: Shares held directly by Chelvey International Limited. E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. The Reporting Person, as the managing partner of E15 Fund II, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund II, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund II, LP, except to the extent of any pecuniary interest therein.
F5: Shares held directly by E15 Fund Advisors (HK) Limited. The Reporting Person, as the managing partner of E15 Fund Advisors (HK) Limited, may be deemed to share voting and dispositive power over the shares held by E15 Fund Advisors (HK) Limited. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund Advisors (HK) Limited, except to the extent of any pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 10, 2023 Filed May 12, 2023 18:42 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | PurchaseClass A Common Stock | 7,000 | $1.99 | $13,958.00 |
DisclosureSEC source: 0001213900-23-038919 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By E15 Fund III, LP Disclosed balance after: 730,332 F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction. F2 · price: This figure is the weighted average purchase price of multiple transactions ranging from $1.9584 to $2.0450 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares purchased at each separate price upon request. F3 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein. Read SEC document |
| April 11, 2023 Filed Apr 13, 2023 00:43 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | PurchaseClass A Common Stock | 17,002 | $2.26 | $38,407.52 |
DisclosureSEC source: 0001213900-23-029225 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By E15 Fund III, LP Disclosed balance after: 723,332 F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction. F2 · price: This figure is the weighted average purchase price of multiple transactions ranging from $2.249 to $2.277 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares purchased at each separate price upon request. F3 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein. Read SEC document |
| April 10, 2023 Filed Apr 11, 2023 17:45 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | PurchaseClass A Common Stock | 5,925 | $2.20 | $13,035.00 |
DisclosureSEC source: 0001213900-23-028787 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By E15 Fund III, LP Disclosed balance after: 5,925 F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction. F2 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 18:49 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | PurchaseClass A Common Stock | 3,000 | $2.05 | $6,150.00 |
DisclosureSEC source: 0001213900-23-028545 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By E15 Fund III, LP Disclosed balance after: 700,405 F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction. F2 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein. Read SEC document |
| March 28, 2023 Filed Mar 30, 2023 20:29 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | PurchaseClass A Common Stock | 74,300 | $2.32 | $172,227.40 |
DisclosureSEC source: 0001213900-23-024675 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By E15 Fund III, LP Disclosed balance after: 697,405 F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction. F2 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein. Read SEC document |
| March 27, 2023 Filed Mar 29, 2023 20:08 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | PurchaseClass A Common Stock | 73,900 | $2.07 | $152,973.00 |
DisclosureSEC source: 0001213900-23-024084 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By E15 Fund III, LP Disclosed balance after: 623,105 F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction. F2 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein. Read SEC document |
| March 24, 2023 Filed Mar 28, 2023 21:00 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | PurchaseClass A Common Stock | 60,125 | $1.65 | $99,146.13 |
DisclosureSEC source: 0001213900-23-023726 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By E15 Fund III, LP Disclosed balance after: 549,205 F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction. F2 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein. Read SEC document |
| March 23, 2023 Filed Mar 27, 2023 20:39 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | PurchaseClass A Common Stock | 73,500 | $1.71 | $125,538.00 |
DisclosureSEC source: 0001213900-23-023222 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By E15 Fund III, LP Disclosed balance after: 489,080 F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction. F2 · price: This figure is the weighted average purchase price of multiple transactions ranging from $1.770 to $1.560 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares purchased at each separate price upon request. F3 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 18:11 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | PurchaseClass A Common Stock | 49,800 | $2.37 | $117,781.98 |
DisclosureSEC source: 0001213900-23-019885 · ownership.xml · nonDerivative · entry 2 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By E15 Fund III, LP Disclosed balance after: 415,580 F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction. F2 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 18:11 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | PurchaseClass A Common Stock | 9,300 | $2.32 | $21,584.37 |
DisclosureSEC source: 0001213900-23-019885 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By E15 Fund III, LP Disclosed balance after: 365,780 F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction. F2 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein. Read SEC document |
| March 09, 2023 Filed Mar 10, 2023 22:08 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | PurchaseClass A Common Stock | 37,100 | $2.50 | $92,623.86 |
DisclosureSEC source: 0001213900-23-019257 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By E15 Fund III, LP Disclosed balance after: 356,480 F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction. F2 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 20:58 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | PurchaseClass A Common Stock | 30,000 | $2.60 | $77,952.00 |
DisclosureSEC source: 0001213900-23-017207 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By E15 Fund III, LP Disclosed balance after: 319,380 F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction. F2 · price: This figure is the weighted average purchase price of multiple transactions ranging from $2.6880 to $2.5264 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares purchased at each separate price upon request. F3 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 18:34 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | PurchaseClass A Common Stock | 37,500 | $2.86 | $107,141.25 |
DisclosureSEC source: 0001213900-23-014708 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By E15 Fund III, LP Disclosed balance after: 289,380 F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction. F2 · price: This figure is the weighted average purchase price of multiple transactions ranging from $2.77 to $2.92 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares purchased at each separate price upon request. F3 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 15:03 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | PurchaseClass A Common Stock | 12,500 | $2.83 | $35,432.50 |
DisclosureSEC source: 0001213900-23-014153 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By E15 Fund III, LP Disclosed balance after: 251,880 F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction. F2 · price: This figure is the weighted average purchase price of multiple transactions ranging from $2.79 to $2.89 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares purchased at each separate price upon request. F3 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 15:24 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | PurchaseClass A Common Stock | 1,200 | $3.02 | $3,618.72 |
DisclosureSEC source: 0001213900-23-012313 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By E15 Fund III, LP Disclosed balance after: 239,380 F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction. F2 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein. Read SEC document |
| February 13, 2023 Filed Feb 14, 2023 21:41 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | PurchaseClass A Common Stock | 15,700 | $3.12 | $48,968.30 |
DisclosureSEC source: 0001213900-23-011558 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By E15 Fund III, LP Disclosed balance after: 238,180 F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.095 to $3.13 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. F3 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein. Read SEC document |
| February 10, 2023 Filed Feb 13, 2023 22:25 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | PurchaseClass A Common Stock | 60,480 | $3.06 | $185,008.32 |
DisclosureSEC source: 0001213900-23-010869 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By E15 Fund III, LP Disclosed balance after: 222,480 F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.944 to $3.08 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. F3 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 00:29 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | PurchaseClass A Common Stock | 79,009 | $3.05 | $240,740.42 |
DisclosureSEC source: 0001213900-23-010431 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By E15 Fund III, LP Disclosed balance after: 162,000 F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.966 to $3.10 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. F3 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 23:32 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | PurchaseClass A Common Stock | 56,180 | $3.08 | $172,955.75 |
DisclosureSEC source: 0001213900-23-009901 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By E15 Fund III, LP Disclosed balance after: 82,991 F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.013 to $3.10 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. F3 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein. Read SEC document |
| February 06, 2023 Filed Feb 9, 2023 02:00 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | PurchaseClass A Common Stock | 26,811 | $3.05 | $81,773.55 |
DisclosureSEC source: 0001213900-23-009493 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,218,338 F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.02 to $3.0609 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| February 06, 2023 Filed Feb 9, 2023 23:30 UTC Amendment | Vicarious Surgical Inc. RBOT · Entity 8714 | PurchaseClass A Common Stock | 26,811 | $3.05 | $81,773.55 |
DisclosureSEC source: 0001213900-23-009900 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By E15 Fund III, LP Disclosed balance after: 26,811 F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction. F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.02 to $3.0609 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. F3 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein. Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 21:31 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | GrantClass A Common Stock | 6,207 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-23-000868 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,191,527 F1 · price: Restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy in lieu of $12,537.50 of cash retainer fees earned during the fourth quarter of 2022. The RSUs were fully vested on the grant date. Read SEC document |
| November 10, 2022 Filed Nov 14, 2022 17:33 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 15,000 | $3.59 | $53,850.00 |
DisclosureSEC source: 0001213900-22-071896 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,185,320 F1 · price: This figure is the weighted average sales price of multiple trades ranging from $3.45 to $3.714 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 14:11 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | GrantClass A Common Stock | 3,743 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-22-061578 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,200,320 F1 · price: Restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy in lieu of $12,538 of cash retainer fees earned during the third quarter of 2022. The RSUs were fully vested on the grant date. Read SEC document |
| September 16, 2022 Filed Sep 20, 2022 14:42 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 12,500 | $3.81 | $47,662.50 |
DisclosureSEC source: 0001213900-22-057220 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,196,577 F1 · price: This figure is the weighted average sales price of multiple trades ranging from $3.80 to $3.86 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| September 15, 2022 Filed Sep 16, 2022 19:03 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 5,700 | $4.23 | $24,136.65 |
DisclosureSEC source: 0001213900-22-056560 · ownership.xml · nonDerivative · entry 2 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,209,077 F2 · price: This figure is the weighted average sales price of multiple trades ranging from $4.250 to $4.330 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 19:03 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 7,600 | $4.28 | $32,520.40 |
DisclosureSEC source: 0001213900-22-056560 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,214,777 F1 · price: This figure is the weighted average sales price of multiple trades ranging from $4.200 to $4.3037 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| September 12, 2022 Filed Sep 13, 2022 19:57 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 11,943 | $4.48 | $53,552.41 |
DisclosureSEC source: 0001213900-22-055593 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,222,377 F1 · price: This figure is the weighted average sales price of multiple trades ranging from $4.410 to $4.534 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| September 09, 2022 Filed Sep 12, 2022 20:32 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 8,057 | $4.43 | $35,668.34 |
DisclosureSEC source: 0001213900-22-055330 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,234,320 F1 · price: This figure is the weighted average sales price of multiple trades ranging from $4.400 to $4.5173 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 16:59 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | OtherClass A Common Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-053075 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By E15 Fund Advisors (HK) Limited Disclosed balance after: 300,001 F1 · kind: E15 Fund Advisors (HK) Limited distributed these shares to its members on a pro rata basis, for no consideration. F2 · ownership.nature: Shares held directly by E15 Fund Advisors (HK) Limited. The Reporting Person, as the managing partner of E15 Fund Advisors (HK) Limited, may be deemed to share voting and dispositive power over the shares held by E15 Fund Advisors (HK) Limited. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund Advisors (HK) Limited, except to the extent of any pecuniary interest therein. Read SEC document |
| August 11, 2022 Filed Aug 12, 2022 15:05 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 16,109 | $4.36 | $70,203.02 |
DisclosureSEC source: 0001213900-22-047171 · ownership.xml · nonDerivative · entry 2 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,242,377 F2 · price: This figure is the weighted average sales price of multiple trades ranging from $4.20 to $4.49 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 15:05 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 3,891 | $4.24 | $16,486.17 |
DisclosureSEC source: 0001213900-22-047171 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,258,486 F1 · price: This figure is the weighted average sales price of multiple trades ranging from $4.20 to $4.30 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| June 30, 2022 Filed Jul 11, 2022 20:06 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | GrantClass A Common Stock | 4,264 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-22-038538 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,262,377 F1 · price: Restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy in lieu of $12,538 of cash retainer fees earned during the second quarter of 2022. The RSUs were fully vested on the grant date. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 20:03 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 20,000 | $4.56 | $91,290.00 |
DisclosureSEC source: 0001213900-22-031756 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,258,113 F1 · price: This figure is the weighted average sales price of multiple trades ranging from $4.515 to $4.595 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:20 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | GrantClass A Common Stock | 38,031 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-22-031150 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,278,113 F1 · price: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in twelve equal monthly installments following the date of grant, subject to the Reporting Person's continued service to Vicarious Surgical Inc. through the applicable vesting date. Read SEC document |
| May 31, 2022 Filed Jun 1, 2022 20:17 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 28,000 | $4.24 | $118,652.80 |
DisclosureSEC source: 0001213900-22-030681 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,240,082 F1 · price: This figure is the weighted average sales price of multiple trades ranging from $4.040 to $4.404 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| May 13, 2022 Filed May 16, 2022 20:00 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 29,200 | $3.92 | $114,458.16 |
DisclosureSEC source: 0001213900-22-027062 · ownership.xml · nonDerivative · entry 2 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,268,082 F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.55 to $3.93 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| May 12, 2022 Filed May 16, 2022 20:00 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | SaleClass A Common Stock | 15,000 | $3.61 | $54,147.00 |
DisclosureSEC source: 0001213900-22-027062 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,297,282 F1 · price: This figure is the weighted average sales price of multiple trades ranging from $3.54 to $3.61 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request. Read SEC document |
| April 29, 2022 Filed May 2, 2022 21:37 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | OtherClass A Common Stock | 132,995 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-023278 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Chelvey International Limited Disclosed balance after: 43,888 F1 · kind: Chelvey International Limited distributed these shares to its sole shareholder, E15 Fund II, LP, on a pro rata basis, for no consideration. In connection with such distribution, E15 Fund II, LP subsequently distributed these shares to its limited partners on a pro rata basis, for no consideration. F2 · ownership.nature: Shares held directly by Chelvey International Limited. E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. The Reporting Person, as the managing partner of E15 Fund II, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund II, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund II, LP, except to the extent of any pecuniary interest therein. Read SEC document |
| April 19, 2022 Filed Apr 21, 2022 00:30 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | OtherClass A Common Stock | 526,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-020859 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By E15 Fund Advisors (HK) Limited Disclosed balance after: 330,001 F1 · kind: E15 Fund Advisors (HK) Limited distributed these shares to its members, on a pro rata basis, for no consideration. F2 · ownership.nature: Shares held directly by E15 Fund Advisors (HK) Limited. The Reporting Person, as the managing partner of E15 Fund Advisors (HK) Limited, may be deemed to share voting and dispositive power over the shares held by E15 Fund Advisors (HK) Limited. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund Advisors (HK) Limited, except to the extent of any pecuniary interest therein. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 23:53 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | OtherClass A Common Stock | 1,007,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-018522 · ownership.xml · nonDerivative · entry 4 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,308,799 F3 · kind: E15 Fund Advisors (HK) Limited distributed these shares to its members, including the Reporting Person, on a pro rata basis, for no consideration. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 23:53 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | OtherClass A Common Stock | 1,197,748 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-018522 · ownership.xml · nonDerivative · entry 3 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By E15 Fund Advisors (HK) Limited Disclosed balance after: 856,180 F3 · kind: E15 Fund Advisors (HK) Limited distributed these shares to its members, including the Reporting Person, on a pro rata basis, for no consideration. F4 · ownership.nature: Shares held directly by E15 Fund Advisors (HK) Limited. The Reporting Person, as the managing partner of E15 Fund Advisors (HK) Limited, may be deemed to share voting and dispositive power over the shares held by E15 Fund Advisors (HK) Limited. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund Advisors (HK) Limited, except to the extent of any pecuniary interest therein. Read SEC document |
| April 01, 2022 Filed Apr 6, 2022 23:53 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | OtherClass A Common Stock | 1,753,928 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-018522 · ownership.xml · nonDerivative · entry 2 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By E15 Fund Advisors (HK) Limited Disclosed balance after: 2,053,928 F1 · kind: Chelvey International Limited distributed these shares to its sole shareholder, E15 Fund II, LP, on a pro rata basis, for no consideration. In connection with such distribution, E15 Fund II, LP subsequently distributed these shares to its limited partners, including E15 Fund Advisors (HK) Limited, on a pro rata basis, for no consideration. F4 · ownership.nature: Shares held directly by E15 Fund Advisors (HK) Limited. The Reporting Person, as the managing partner of E15 Fund Advisors (HK) Limited, may be deemed to share voting and dispositive power over the shares held by E15 Fund Advisors (HK) Limited. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund Advisors (HK) Limited, except to the extent of any pecuniary interest therein. Read SEC document |
| April 01, 2022 Filed Apr 6, 2022 23:53 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | OtherClass A Common Stock | 1,833,725 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-018522 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Chelvey International Limited Disclosed balance after: 176,883 F1 · kind: Chelvey International Limited distributed these shares to its sole shareholder, E15 Fund II, LP, on a pro rata basis, for no consideration. In connection with such distribution, E15 Fund II, LP subsequently distributed these shares to its limited partners, including E15 Fund Advisors (HK) Limited, on a pro rata basis, for no consideration. F2 · ownership.nature: Shares held directly by Chelvey International Limited. E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. The Reporting Person, as the managing partner of E15 Fund II, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund II, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund II, LP, except to the extent of any pecuniary interest therein. Read SEC document |
| March 31, 2022 Filed May 4, 2022 22:32 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | GrantClass A Common Stock | 2,283 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-22-024032 · ownership.xml · nonDerivative · entry 2 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,312,282 F2 · price: RSUs granted to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of $11,550 of cash retainer fees earned during the first quarter of 2022. The RSUs were fully vested on the grant date. Read SEC document |
| March 22, 2022 Filed Mar 23, 2022 23:56 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | OtherClass A Common Stock | 53,198 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-014597 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Chelvey International Limited Disclosed balance after: 2,010,608 F1 · kind: Chelvey International Limited distributed these shares to its sole shareholder, E15 Fund II, LP, on a pro rata basis, for no consideration. In connection with such distribution, E15 Fund II, LP subsequently distributed these shares to its limited partners on a pro rata basis, for no consideration. F2 · ownership.nature: Shares held directly by Chelvey International Limited. E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. The Reporting Person, as the managing partner of E15 Fund II, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund II, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund II, LP, except to the extent of any pecuniary interest therein. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 23:56 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | OtherClass A Common Stock | 59,848 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-014597 · ownership.xml · nonDerivative · entry 2 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Chelvey International Limited Disclosed balance after: 2,063,806 F1 · kind: Chelvey International Limited distributed these shares to its sole shareholder, E15 Fund II, LP, on a pro rata basis, for no consideration. In connection with such distribution, E15 Fund II, LP subsequently distributed these shares to its limited partners on a pro rata basis, for no consideration. F2 · ownership.nature: Shares held directly by Chelvey International Limited. E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. The Reporting Person, as the managing partner of E15 Fund II, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund II, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund II, LP, except to the extent of any pecuniary interest therein. Read SEC document |
| March 17, 2022 Filed Mar 21, 2022 23:14 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | GrantClass A Common Stock | 265,990 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-013929 · ownership.xml · nonDerivative · entry 2 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,699 F1 · kind: Chelvey International Limited distributed these shares to its sole shareholder, E15 Fund II, LP, on a pro rata basis, for no consideration. In connection with such distribution, E15 Fund II, LP subsequently distributed these shares to its limited partner, Mr. Liang, on a pro rata basis, for no consideration. F3 · balance_after: Consists of (i) 265,990 shares of Class A Common Stock held by Mr. Liang and (ii) 35,709 restricted stock units ("RSUs") held by Mr. Liang. Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in 36 equal monthly installments beginning on September 20, 2021, provided that the initial three months of vesting will not occur until December 20, 2021, subject to Mr. Liang's continued service through the applicable vesting date. Read SEC document |
| March 17, 2022 Filed Mar 21, 2022 23:14 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | OtherClass A Common Stock | 265,990 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-013929 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Chelvey International Limited Disclosed balance after: 2,123,654 F1 · kind: Chelvey International Limited distributed these shares to its sole shareholder, E15 Fund II, LP, on a pro rata basis, for no consideration. In connection with such distribution, E15 Fund II, LP subsequently distributed these shares to its limited partner, Mr. Liang, on a pro rata basis, for no consideration. F2 · ownership.nature: Shares held directly by Chelvey International Limited. E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. The Reporting Person, as the managing partner of E15 Fund II, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund II, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund II, LP, except to the extent of any pecuniary interest therein. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:50 UTC | Vicarious Surgical Inc. RBOT · Entity 8714 | OtherClass A Common Stock | 66,497 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-010770 · ownership.xml · nonDerivative · entry 1 Liang Philip · CIK 0001883781 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Chelvey International Limited Disclosed balance after: 2,389,644 F1 · kind: Chelvey International Limited distributed these shares to its sole shareholder, E15 Fund II, LP, on a pro rata basis, for no consideration. In connection with such distribution, E15 Fund II, LP subsequently distributed these shares to its limited partners on a pro rata basis, for no consideration. F2 · ownership.nature: Shares held directly by Chelvey International Limited. E15 Fund II, LP, the sole shareholder of Chelvey International Limited, may be deemed to have sole voting and dispositive power over the shares held by Chelvey International Limited. The Reporting Person, as the managing partner of E15 Fund II, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund II, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund II, LP, except to the extent of any pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.